History and prospects for pharmaceutical Good Manufacturing Practices inspectionSUN Jing-lin, YU Bo-yang201-205
Judgement of the same matter subject during verification of patent priority for the inventions in pharmaceutical fieldPAN Ke, CHEN Yan-yan, WU Tong-yi206-210
Bruton's tyrosine kinase inhibitor drugs and its patent researchHUANG Lu, WANG Lin-hai, SUN Jian, HONG Yi211-218
Characteristics of clinical trials of small-molecule kinase inhibitor registered in ClinicalTrials. govXU Hao-yun, QIU Chun-feng, ZHENG Jian-hong219-225
Discussions on common issues of domestic human fibrinogen clinical trialsWANG Yan-lin, RAO Ya-lan, XIONG Wen-xiang, YU Ai-ping, GAO Chen-yan226-230
Research progress on relationship between animal model of glaucoma and human pathogenesisXIONG Ya-ni, MENG Yong, QIAN Yi-min, WANG Ruo-nan, SONG Shuo, LI Hua231-236
Research progress of exosomes in the pathogenesis of type 2 diabetes and its potential as a biomarker for diagnosis and treatmentLIU Sen, GE Jin-fang237-244
Research progress on container-closure integrity regulations and detection technology aseptic preparationYANG Meng-yu, ZHAO Xia, SUN Hui-min245-250
Effect of antipsychotics drugs on liver fat content by ultrasound quantificationSUN Lin-lin, LI Nan, ZHANG Li-gang, CHEN Jing-xu251-256
The contraceptive effect of etonogestrel subcutaneous implantation and the influencing factors of irregular vaginal bleedingLI Jing, HUA Shao-fang257-262